Efficacy of T2 in active Crohn's disease: a prospective study report (Q80101961)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17410440%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

title

Efficacy of T2 in active Crohn's disease: a prospective study report (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17410440%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17410440%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Qingsong Tao

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17410440%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

author name string

Xinbo Wang

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17410440%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Zhiming Wang

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17410440%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Jieshou Li

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17410440%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

publication date

5 April 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17410440%20AND%20SRC:MED&resulttype=core&format=json

Digestive Diseases and Sciences

28 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17410440%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

volume

52

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17410440%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17410440%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

page(s)

1790-1797

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17410440%20AND%20SRC:MED&resulttype=core&format=json

A comparison of budesonide and mesalamine for active Crohn's disease. International Budesonide-Mesalamine Study Group.

28 December 2019

cites work

1 reference

12 December 2020

Celastrol inhibits pro-inflammatory cytokine secretion in Crohn's disease biopsies.

1 reference

12 December 2020

Development and validation of an endoscopic index of the severity for Crohn's disease: a prospective multicentre study. Groupe d'Etudes Thérapeutiques des Affections Inflammatoires du Tube Digestif (GETAID)

1 reference

12 December 2020

European evidence based consensus on the diagnosis and management of Crohn's disease: current management.

1 reference

12 December 2020

Classification of inflammatory bowel disease

1 reference

12 December 2020

Retrospective survey of 452 patients with inflammatory bowel disease in Wuhan city, central China

1 reference

12 December 2020

The Chinese anti-inflammatory and immunosuppressive herbal remedy Tripterygium wilfordii Hook F.

1 reference

12 December 2020

The Chinese herbal remedy, T2, inhibits mitogen-induced cytokine gene transcription by T cells, but not initial signal transduction

1 reference

12 December 2020

Antiinflammatory constituents of Celastrus orbiculatus inhibit the NF-kappaB activation and NO production

1 reference

12 December 2020

An engineered human antibody to TNF (CDP571) for active Crohn's disease: a randomized double-blind placebo-controlled trial

1 reference

12 December 2020

Novel cytokine release inhibitors. Part I: Triterpenes

1 reference

12 December 2020

Resolution of severe lupus nephritis associated with Tripterygium wilfordii hook F ingestion

1 reference

12 December 2020

A potential new treatment for rheumatoid arthritis: thunder god vine

1 reference

12 December 2020

Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study

1 reference

12 December 2020

Tumour necrosis factor α and interleukin 1β in relapse of Crohn's disease

1 reference

12 December 2020

Celastrol, a potent antioxidant and anti-inflammatory drug, as a possible treatment for Alzheimer's disease

1 reference

12 December 2020

Guidelines for the management of inflammatory bowel disease in adults

1 reference

12 December 2020

Mesalamine capsules for the treatment of active Crohn's disease: results of a 16-week trial. Pentasa Crohn's Disease Study Group

1 reference

12 December 2020

Intestinal permeability in patients with Crohn's disease and their healthy relatives

1 reference

12 December 2020

Effects of the extract of a Chinese herb Tripterygium wilfordii hook f on rat pituitary gland

1 reference

12 December 2020

TNF-alpha-induced increase in intestinal epithelial tight junction permeability requires NF-kappa B activation

1 reference

12 December 2020

National Cooperative Crohn's Disease Study: adverse reactions to study drugs

1 reference

12 December 2020

Triptolide attenuates endotoxin- and staphylococcal exotoxin-induced T-cell proliferation and production of cytokines and chemokines

1 reference

12 December 2020

Radix Tripterygium wilfordii--a Chinese herbal medicine with potent immunosuppressive properties

1 reference

12 December 2020

Immunosuppressant PG490 (triptolide) inhibits T-cell interleukin-2 expression at the level of purine-box/nuclear factor of activated T-cells and NF-kappaB transcriptional activation

1 reference

12 December 2020

Suppression of renal disease and arthritis, and prolongation of survival in MRL-lpr mice treated with an extract of Tripterygium wilfordii Hook f

1 reference

12 December 2020

Chinese herbs as immunomodulators and potential disease-modifying antirheumatic drugs in autoimmune disorders.

1 reference

12 December 2020